<DOC>
	<DOCNO>NCT00800332</DOCNO>
	<brief_summary>The purpose study test whether vaccination CYT003-QbG10 improve allergy symptom patient house dust mite allergy . The active treatment compare placebo .</brief_summary>
	<brief_title>Dose Finding Study With CYT003-QbG10 Patients With House Dust Mite Allergy</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>Perennial allergic rhinoconjunctivitis due clinically relevant allergy towards house dust mite allergen Further criterion define study protocol Clinically manifest seasonal allergy/ies is/are expect interfere patient 's study treatment schedule and/or assessment Clinically relevant perennial allergy/ies house dust mites allergy Contraindication study test procedure Further criterion define study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Rhinoconjunctivitis due house dust mite allergy</keyword>
</DOC>